{
    "2019-07-26": [
        [
            {
                "time": "2018-07-31",
                "original_text": "Pharma Stock Roundup: GSK, BMY Q2 Earnings, FDA Nod to LLY's Hypoglycemia Treatment",
                "features": {
                    "keywords": [
                        "GSK",
                        "BMY",
                        "Q2 Earnings",
                        "FDA",
                        "LLY",
                        "Hypoglycemia Treatment"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-01",
                "original_text": "Senate advances bill to cut the cost of prescriptions",
                "features": {
                    "keywords": [
                        "Senate",
                        "bill",
                        "cut",
                        "cost",
                        "prescriptions"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-08-02",
                "original_text": "EMA panel recommends approving Bayer's cancer drug Vitrakvi",
                "features": {
                    "keywords": [
                        "EMA",
                        "Bayer",
                        "cancer drug",
                        "Vitrakvi"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-07-24",
                "original_text": "Eli Lilly (LLY) Stock Down 6.8% in 2019: Can Q2 Earnings Boost Performance?",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "LLY",
                        "Stock Down",
                        "Q2 Earnings"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}